A
AnaptysBio, Inc.
ANAB · NASDAQ · Healthcare · 1.7B
Closing price
$45.95
-0.56% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
34.3×
Enterprise value / EBITDAEV/EBITDA
15.2×
Free cash flow yieldFCF yield
1.5%
Return on equityROE
-35.6%
Operating margin
20.4%
Net debt / EBITDAbalance-sheet strength
-3.2×
Interest coverage
0.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.